Glycine propionyl-L-carnitine modulates lipid peroxidation and nitric oxide in human subjects
Abstract
Objective: To determine the efficacy of glycine propionyl-L-carnitine (GPLC) to decrease lipid peroxidation, elevate nitric oxide, and improve blood lipid profiles in human subjects. Methods: Thirty untrained, normolipidemic subjects performed eight weeks of supervised aerobic exercise while supplementing GPLC at one of two doses (1 or 3 grams daily of PLC + glycine) or placebo, following random assignment in a double-blind manner. Fasting blood samples were analyzed at rest for malondialdehyde, nitric oxide, and lipids before and after the intervention. Results: Malondialdehyde was decreased (p<0.05) from pre- to post-intervention with 1 g GPLC (1.08±0.24 vs. 0.69±0.25 μmol·L -1) and 3 g GPLC(0.94±0.18 vs. 0.66±0.17 μmol·L -1), but did not change statistically (p>0.05) with placebo (1.12±0.21 vs. 1.03±0.23 μmol·L -1). Nitric oxide was increased (p<0.05) from pre- to post-intervention with 3 g GPLC (21.34±2.27 vs. 29.46±3.61 μmol·L -1), but did not change statistically (p>0.05) with 1 g GPLC (23.22±4.13 vs. 26.24±4.32 μmol·L -1) or placebo (24.31±3.90 vs. 26.14±4.11 μmol·L -1). No main effects or interaction effects were noted for blood lipids (p>0.05). Conclusion: GPLC supplementation combinedwith eight weeks of aerobic exercise decreases lipid peroxidation and elevates nitric oxide, but does not further improve blood lipid profiles in normolipidemic subjects. © Hogrefe & Huber Publishers.
Publication Title
International Journal for Vitamin and Nutrition Research
Recommended Citation
Bloomer, R., Tschume, L., & Smith, W. (2009). Glycine propionyl-L-carnitine modulates lipid peroxidation and nitric oxide in human subjects. International Journal for Vitamin and Nutrition Research, 79 (3), 131-141. https://doi.org/10.1024/0300-9831.79.3.131
